Shorter radiation with extra focus on tumor site for breast cancer
Part of Cancer, Skin clinical trials.
This trial tests a shorter course of radiation therapy that includes an extra dose to the tumor site for women with early-stage breast cancer. It aims to make treatment more convenient and effective after breast-conserving surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman diagnosed with early-stage breast cancer (stages T1-2, N0-1) or a non-invasive breast condition called DCIS.
- You have had breast-conserving surgery (lumpectomy).
- You are 20 years or older.
- You are generally active and able to care for yourself (Karnofsky score of 70% or higher).
- Your life expectancy is at least 5 years.
- Your kidneys and liver are working well enough based on standard lab tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter, more targeted course of daily radiation for early-stage breast cancer. The radiation plan is adjusted each day to better fit your body, which may reduce side effects.
This trial tests a shorter course of radiation (fewer, larger doses) after breast-conserving surgery for early-stage breast cancer. The goal is to see if this approach is safe and effective for people with a low risk of cancer spread.
This trial tests a shorter, more intense course of daily radiation therapy (called ultra hypo-fractionation) given after lumpectomy for early-stage breast cancer. The goal is to reduce the number of treatment visits while keeping the same high level of effectiveness and safety.
This trial studies giving whole-breast radiation in a shorter, more concentrated way after breast-conserving surgery. It aims to see if this “ultra-short” schedule is effective and safe for people with early breast cancer.
This trial compares a shorter, more concentrated radiation schedule versus a standard shorter schedule after breast-conserving surgery. It looks at whether the treatment works well and is safe, especially for women whose lymph nodes also need radiation.
This trial studies a radiation technique that treats only part of the breast using a faster schedule. It may help some people with early breast cancer after breast-conserving surgery by delivering effective treatment with less radiation to the rest of the breast.
Hear when a new Early Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.